ArticleCancer research2010

Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response.

Josie Ursini-Siegel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.